baber/WOPTO huggingface dataset:
Patent AU-2020229437-A1 (AU)
Title: Brain stimulation system, device, arrangement and corresponding method for treating aphasia
Inventor: MALEJ KRZYSZTOF MATEUSZ
IPC: A61N1/36
Filed: 2020-02-25
Abstract: The disclosure relates to a brain stimulation system (102), comprising: a) a computer program product, e.g. a data carrier, preferably a non-transitory data carrier, or a data stream, comprising program code (P1, P1a) which, when loaded and executed on an electronic control unit (108), provides an operation control system, or b) an electronic control unit (108) with a program code (P1, P1a) loaded on the electronic control unit (108), wherein the program code (P1, P1a), when executed on the electronic control unit (108), provides an operation control system (200), wherein the operation control system (200) is configured to control a brain training and/or stimulation session for a brain, and wherein the operation control system (200) comprises a plurality of control system functionalities, the control system functionalities comprising: - a stimulation functionality (202) which is configured to cause the electronic control unit (108) to issue a stimulation command to an electrical brain stimulation device (122) to cause the electrical brain stimulation device (122) to perform an electrical brain stimulation procedure; and - a presentation functionality (204) which is configured to cause the electronic control unit (108) to issue a presentation command in order to present a task to be performed by a user (120) on a user interface (110), wherein preferably the stimulation functionality (202) and the presentation functionality (204) are linked (254 to 262) or linkable to one another.
Patent AU-2020246951-A1 (AU)
Title: Load-handling device
Inventor: POPA DANIEL
IPC: B65G1/04
Filed: 2020-03-20
Abstract: A load-handling device (100) is provided for lifting and moving containers (10) stacked in stacks (12) in a storage system (1). The load-handling device (100) includes a body (102); a wheel assembly arranged to support the body (102); a container-lifting mechanism configured to lift a container into or out of the body (102); and a wheel- positioning mechanism comprising wheel-engaging means for selectively engaging either a first set of wheels (116) of the wheel assembly with a first set of rails or tracks (22a) of the storage system (1), or a second set of wheels (118) of the wheel assembly with a second set of rails or tracks (22b) of the storage system (1). The wheel-engaging means may comprise at least one non-vertically-orientated linear actuator and/or at least one eccentric-rotation-based wheel-engaging means.
Patent AU-2020248351-A1 (AU)
Title: Personalized digital therapy methods and devices
Inventor: VAUGHAN BRENT
IPC: A61B5/00
Filed: 2020-03-20
Abstract: The platforms, systems, devices, methods and media disclosed herein can evaluate a subject for a developmental condition or conditions and provide enhanced digital therapeutics. The platforms, systems, devices, methods and media disclosed herein can be configured to improve the developmental condition or conditions based on digital feedback.
Patent AU-2020250810-A1 (AU)
Title: Anticancer combination therapy
Inventor: ZINZALLA VITTORIA
IPC: A61K39/395
Filed: 2020-03-26
Abstract: The invention describes anti-cancer therapies comprising using an polypeptide capable of specifically binding to LRP5 and LRP6 in combination with an anti-PD1 antibody, each as described herein.
Patent AU-2020266420-A1 (AU)
Title: Device for transport and treatment of liquid
Inventor: AGA MORTEN
IPC: A01K61/10
Filed: 2020-04-29
Abstract: Device (10) for transporting a liquid from a first location to a second location characterized in that the device (10) comprises a conduit (16) for transporting the liquid from a first location to a second location, where the upper portion of the conduit (16) has the shape of an arch (30) establishing a space above the liquid surface, and wherein the conduit (16) comprises a first upstream conduit portion (16a) for receiving of liquid from said first location, and one or more outflow portions (16g) arranged in an upper portion of the conduit (16) in order to discharge liquid out of the conduit (16), and where there is arranged means (17) for supplying microbubbles in the upstream conduit portion (16a) to the conduit portion (16), where the length of upstream conduit portion (16a) and the position of the of outflow portion (16g) are arranged so that liquid is received in the conduit (16) from a first location at a certain depth in a volume of liquid and that liquid is expelled from the outflow conduit portion (16g) at a second location, that is vertically higher in the liquid volume than the first location.
Patent AU-2020277403-A1 (AU)
Title: Compositions and methods of manufacturing trivalent filovirus vaccines
Inventor: DONINI OREOLA
IPC: A61K39/00
Filed: 2020-05-20
Abstract: Disclosed is a stable immunogenic composition capable of eliciting a robust and durable immune response, comprising at least one antigen consisting of a filovirus glycoprotein and at least one nano-emulsion adjuvant which are co-lyophilized and can be reconstituted immediately prior to use. Also disclosed is a vaccine composition comprising at least two antigens, wherein each antigen is specific to a different genus of filovirus and which also comprises at least one nano-emulsion adjuvant.
Patent AU-2020281131-A1 (AU)
Title: Logistics managing method and electronic apparatus performing same
Inventor: YIM SANG HO
IPC: G06Q50/28
Filed: 2020-09-07
Abstract: A logistics managing method according to example embodiments may include 
identifying at least one tote included in a tote set, identifying a station set corresponding 
to the tote set among at least one station set based on an attribute of an item included in 
5 the at least one tote, and determining one of the at least one station included in the station 
set to be a destination of the at least one tote. Other various embodiments are also 
possible.
Patent AU-2020281943-A1 (AU)
Title: Substituted 4-(5-(benzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid compounds for use in therapy for neuropathic pain
Inventor: CORCORAN JONATHAN PATRICK THOMAS
IPC: A61P25/02
Filed: 2020-05-29
Abstract: The present invention pertains generally to the field of therapy. More specifically, the present invention pertains to certain substituted 4-[5-(benzofuran-2-yl)-1,2,4-oxadiazol-3-yl]benzoic acid compounds (collectively referred to herein as BOBA compounds), and pharmaceutical compositions comprising those compounds, for use in a method of treatment or prevention of neuropathic pain. (Formula (A))
Patent AU-2020294175-A1 (AU)
Title: Underbody shield composition and articles that provide enhanced peel strength and methods of using them
Inventor: MASON MARK O
IPC: F41H5/06
Filed: 2020-12-22
Abstract: A thermoplastic composite article comprising a porous core layer comprising a plurality of 
reinforcing fibers, a lofting agent and a thermoplastic material is provided. In certain instances, 
the article further comprises a skin layer disposed on the core layer and an adhesive layer 
between the core layer and the skin layer. In some configurations, the adhesive layer comprises 
a thermoplastic polymer and an effective amount of a thermosetting material to provide a post
molding peel strength between the skin layer and the post lofted core layer of at least 0.5 N/cm 
(in either or both of the machine direction or cross direction) as tested by DIN 53357 A dated 
October 1, 1982.  
Fig 9.
WO 2016/183079 PCT/US2016/031643 
5/9 
920 900 
915 
910 
FIG. 9 
1020 1000 
1015 
1010 
1030 
FIG. 10 
1130 
1120 1100 
1115 
1110 
FIG. 11
Patent AU-2020295391-A1 (AU)
Title: Providing resistance to separation of catheter adapter and a needle hub
Inventor: HARDING WESTON F
IPC: A61M25/06
Filed: 2020-06-17
Abstract: A catheter system 10 including a catheter adapter and a wing 24 extending outwardly from the catheter adapter. The wing includes a groove or slot 40. The system includes a needle hub 12 and a paddle 14 extending outwardly from the needle hub. The paddle includes an extension 42 disposed within the groove or the slot to reduce axial movement between the catheter adapter and the needle hub. The extension may be removable from the groove or the slot to allow axial movement between the catheter adapter and the needle hub during removal of the needle hub from the catheter adapter, for example. The paddle and/or the wing may include a shape to reduce axial movement between the catheter adapter and the needle hub, which may also be advantageous during insertion of the catheter system.
Patent AU-2020342713-A1 (AU)
Title: Compositions and methods for treating extensive stage small cell lung cancer (ES-SCLC)
Inventor: JIANG HAIYI
IPC: C07K16/32
Filed: 2020-09-04
Abstract: Disclosed are methods for treating extensive-stage small-cell lung cancer (ES-SCLC) with an antibody that inhibits PD1/PD-L1 activity in combination with etoposide and a platinum- based therapeutic agent.
Patent AU-2020351159-A1 (AU)
Title: Protein tag to induce ligand dependent degradation of protein/protein-fusions
Inventor: FISCHER ERIC S
IPC: A61K48/00
Filed: 2020-09-17
Abstract: Described herein are compositions and methods for modulating protein abundance in a target-specific manner via degron tags.
Patent AU-2020351874-A1 (AU)
Title: Tracker for a surgical instrument
Inventor: GHANAM FADI
IPC: A61B17/00
Filed: 2020-09-28
Abstract: An optical tracker usable with a handheld surgical instrument, the optical tracker includes a tracker frame including a mounting body, which defines an instrument engaging aperture having a longitudinal axis, and an offset body protruding proximally from the mounting body. The instrument engaging aperture is configured to receive a proximal region of the surgical instrument such that the longitudinal axis of the tracker is aligned with an axis of the surgical instrument. Three radial segments of equal proportion are defined about the longitudinal axis and collectively encircle the longitudinal axis. The tracker further includes at least six markers arranged to form at least two arrays coupled to the tracker frame and positioned such that at least one marker is positioned within each radial segment. A portion of each of arrays is coupled to the offset body and positioned proximally of the mounting body.
Patent AU-2020368354-A1 (AU)
Title: CLEC12A antibody fragment sequences and methods
Inventor: FELICES MARTIN
IPC: C07K16/28
Filed: 2020-10-14
Abstract: An anti-CLEC12A polypeptide generally includes an amino acid sequence having at least 90% amino acid similarity to SEQ ID NO:14. In some embodiments, anti-CLEC12A polypeptide may be incorporated into an anti-CLEC12A biologic. In some of these embodiments, the anti-CLEC12A biologic can be a bi-specific Killer engager molecule (BiKE), a tri-specific Killer engager molecule (TriKE), a tetra-specific Killer engager molecule (TetraKE), a penta-specific Killer engager molecule (PentaKE), a bi-specific T cell engager molecule (BiTE), a tri-specific T cell engager molecule (TriTE), tetra-specific T cell engager molecule (TetraTE), a penta-specific T cell engager molecule (PentaTE), a chimeric antigen receptor, a full antibody, an antibody-drug conjugate (ADC) molecule, a targeted delivery construct, or a labeling construct.
Patent AU-2020372413-A1 (AU)
Title: TGF-beta polypeptides
Inventor: SEIDEL III RONALD D
IPC: C07K19/00
Filed: 2020-10-22
Abstract: The present disclosure provides Transforming Growth Factor Beta (TGF-β) polypeptide constructs and complexes that find use in, for example, therapeutic treatment of diseases including autoimmune diseases. Also described are nucleic acids that encode the constructs and complexes and methods of preparing the constructs and complexes in cell-based expression systems.
Patent AU-2020394404-A1 (AU)
Title: Methods, devices, and systems for physiological parameter analysis
Inventor: XU YONGJIN
IPC: G16H20/17
Filed: 2020-11-24
Abstract: A method for deriving physiological parameters may include: measuring a glucose level of a subject over time; measuring a HbA1c of individual red blood cells in a sample comprising a plurality of red blood cells; deriving a measured cellular HbA1c distribution of the sample; and calculating at least one physiological parameter selected from the group consisting of (a) a red blood cell elimination constant (k
Patent AU-2020398170-A1 (AU)
Title: Holographic display device and method of use
Inventor: NUSSBAUM DAVID
IPC: G03H1/04
Filed: 2020-12-04
Abstract: A holographic display device for presenting a hologram-like image and a method of use are disclosed. The holographic display device includes a box-like structure, a translucent panel, and light panels extending the entire length of the box-like structure. The light panels position between the box-like structure and the translucent panel. The holographic display device includes a transparent monitor connecting the box-like structure at its front end. The transparent monitor receives and displays an image. The light panels illuminate light and the translucent panel diffuses, blends, and evenly distributes the light in the interior. Transmitted shadowing to the monitor provides a realistic appearance. A unique image capturing system for capturing the image to be displayed on the transparent monitor is also disclosed. The image capturing system transmits the image to the holographic display device in real-time or as a pre-recorded image using wired or wireless protocols.
Patent AU-2020403708-A1 (AU)
Title: Material conveying device
Inventor: ZHANG XIAOFENG
IPC: B65G47/22
Filed: 2020-09-30
Abstract: The present invention provides a material conveying device. The material conveying device 
includes: a material conveying groove, having a traveling track; a material bearing and 
conveying assembly, including: an annular chain; traveling units, arranged on the chain at 
intervals, wherein the traveling units are able to be driven by the chain to move on the 
traveling track along a material conveying direction, and each traveling unit is provided with 
a bottom surface close to the material conveying groove, a top surface opposite to the bottom 
surface and side surfaces extending between the top surface and the bottom surface; a 
belt-shaped elastic material bearing portion, connected to the top surfaces and/or the side 
surfaces of the two adjacent traveling units; and a driving device, being able to drive the chain 
to circularly rotate relative to the material conveying groove along the material conveying 
direction. The working state of material conveying equipment can be improved, and the 
stability and economic index of the equipment can be enhanced.
Patent AU-2020404964-A1 (AU)
Title: Fuel design and shielding design for radioisotope thermoelectric generators
Inventor: MATTHEWS JACOB
IPC: G21H1/00
Filed: 2020-12-16
Abstract: Provided is a fuel design configured to have a thickness that is equal to or less than a mean-free path of electrons emitted by a radioactive energy source to prevent electrons produced thereby from being stopped within the fuel design and thus preventing bremsstrahlung radiation from being generated within the fuel design. Additionally provided is a two-phase shielding system including a first shield formed of a first material having a thickness exceeding a mean- free path of an electron emitted from a radioactive source material so as to prevent the electron from passing through the first shield, and a second shield formed of a second material configured to prevent bremsstrahlung radiation generated by the electron from passing through the second shield.
Patent AU-2021200572-A1 (AU)
Title: Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome
Inventor: EWENSTEIN BRUCE
IPC: A61P7/02
Filed: 2021-01-29
Abstract: The disclosure provides compositions and methods for treating, ameliorating, and/or 
preventing a vaso-occlusive crisis (VOC) in a subject suffering from sickle cell disease 
(SCD). The disclosure also provides compositions and methods for treating, ameliorating, 
and/or preventing lung injury in a subject suffering from or at risk of suffering from acute 
lung injury (ALI) and/or acute respiratory distress syndrome (ARDS). The disclosure 
provides A Disintegrin And Metalloproteinase with Thrombospondin type I motif, member
13 (ADAMTS 13) or a composition comprising ADAMTS 13 for treating, ameliorating, 
and/or preventing the VOC, or for treating, ameliorating, and/or preventing lung injury in a 
subject suffering from or at risk of suffering from ALI and/or ARDS.
Patent AU-2021203092-A1 (AU)
Title: Compositions and methods for peronospora resistance in spinach
Inventor: BRUGMANS BART WILLEM
IPC: C12N15/29
Filed: 2021-05-14
Abstract: The invention provides for spinach plants with broad-spectrum resistance to downy 
mildew disease and their progeny. Such plants may comprise unique combinations of alleles 
resulting in the broad-spectrum resistance to downy mildew. In certain aspects, compositions, 
5 including distinct polymorphic molecular markers, and methods for producing, using, 
identifying, selecting, and the like of plants or germplasm with resistance to downy mildew are 
provided.  
38
Patent AU-2021212014-A1 (AU)
Title: Process and apparatus for treating sludge
Inventor: MCPHERSON JASON
IPC: C02F11/13
Filed: 2021-08-03
Abstract: An apparatus and process for removing moisture from sludge. The apparatus 
comprises a housing having an inlet and outlet for respective receipt and discharge of 
the sludge. A conveyor is located in the housing and is configured to transport the 
5 sludge from the inlet to the outlet. The apparatus further comprises a heater to heat the 
sludge to remove moisture therefrom whilst the sludge is being transported by the 
conveyor. The apparatus also comprises a vacuum pump arranged to extract air from 
the apparatus and, at the same time, to cause moisture removed from the sludge to flow 
therefrom together with the extracted air.  
10
Patent AU-2021218877-A1 (AU)
Title: Protective device and slope stabilization
Inventor: EICHER MANUEL
IPC: E02B5/02
Filed: 2021-02-04
Abstract: The invention relates to a protective device (34a-b), in particular an erosion protection device and/or a drainage device, preferably a geotextile, comprising a mat element (10a-b) which is at least designed to be flatly spread out over a surface (12a-b) to be protected and which is at least mostly made of a composite (14a-b), in particular a three-dimensional fleece-like composite, in particular a tangled fleece-like composite, comprising a plurality of fibers (16a-b). According to the invention, the fibers (16a-b) are designed as biodegradable plastic fibers.
Patent AU-2021223905-A1 (AU)
Title: Process for producing a surface-modified particulate lithium nickel metal oxide material
Inventor: CAIRNS DANIEL
IPC: C01G53/00
Filed: 2021-02-19
Abstract: A process for producing a surface-modified particulate lithium nickel metal oxide material is provided. The process comprises the addition of a controlled quantity of a coating liquid comprising a metal-containing compound and a lithium-containing compound to nickel metal precursor particles using an incipient wetness process followed by a calcination step.
Patent AU-2021232824-A1 (AU)
Title: Electrosurgical apparatus and method
Inventor: MEADOWCROFT SIMON
IPC: A61B18/18
Filed: 2021-09-17
Abstract: An electrosurgical apparatus and method for performing 
thermal treatment in the gastrointestinal tract, e.g. to 
5 ablate duodenal mucosal tissue. The apparatus comprises an 
instrument having a flexible cable and an applicator suitable 
for use with a gastroscope, which can be deployed within a 
patient to delivery energy in a targeted or otherwise 
controllable manner. The applicator can deliver microwave 
10 energy by radiation. The direct and depth-limited nature of 
microwave energy can be make it more effective than treatments 
that rely on thermal conduction. The applicator may include a 
radially extendable portion arranged to move an microwave 
energy delivery structure into contact with duodenal mucosal 
15 tissue at the treatment region. The applicator may comprise 
any of a balloon, bipolar radiator, movable paddle, and 
rotatable roller element.
Patent AU-2021240889-A1 (AU)
Title: Frozen confection
Inventor: CHAMBERLAIN DOROTHY MARGARET
IPC: A23G9/32
Filed: 2021-03-15
Abstract: A frozen confection comprising: 25 wt% to 40 wt% freezing point depressants having a number average molecular weight of 200 g mol
Patent AU-2021245223-A1 (AU)
Title: Niraparib compositions
Inventor: WU GEORGE
IPC: C07D401/10
Filed: 2021-10-08
Abstract: NIRAPARIB COMPOSITIONS 
ABSTRACT 
The present invention relates to compositions comprising the compound niraparib, in particular 
certain solid forms of niraparib.
Patent AU-2021267488-A1 (AU)
Title: Methods for designing an orthodontic appliance
Inventor: ROEIN PEIKAR SEYED MEHDI
IPC: A61C7/28
Filed: 2021-05-01
Abstract: Orthodontic appliances, systems, and methods are disclosed herein. In some examples, an orthodontic appliance can include an anchor configured to be adjacent to the patient's teeth and a plurality of arms extending away from and coupled to the anchor, the arms configured to be secured to the patient' s teeth. According to embodiments of the present technology, methods for determining a design of an orthodontic appliance can include virtually deforming an appliance digital model based on an anatomy digital model and, based on an output of the virtual deformation, modifying one or more digital models or producing a final design of an orthodontic appliance. If one or more digital models is modified, the method is repeated until a final design is produced.
Patent AU-2021269285-A1 (AU)
Title: Implantable medical devices and methods for real-time or near real-time adjustment of diaphragmatic stimulation parameters to affect pressures within the intrathoracic cavity
Inventor: BAUER PETER T
IPC: A61B5/352
Filed: 2021-11-15
Abstract: A controller detects a cyclic cardiac event of the patient based on a signal obtained from one or 
more electrodes configured for placement on or near a diaphragm, and delivers an electrical 
stimulation therapy to a diaphragm of the patient through the one or more electrodes. The delivery 
of electrical stimulation therapy is timed to the detection of the cyclic cardiac event, and the 
electrical stimulation therapy is defined by stimulation parameters. The controller monitors a 
pressure associated with the intrathoracic cavity of the patient based on a signal provided by a 
pressure measurement source configured to provide a signal indicative of a pressure within an 
intrathoracic cavity, to determine whether an adjustment of one or more of the stimulation 
parameters is warranted.  
Figure 6A
11/24 
Derive a measure of interest from 
each obtained heart sound signals 
(from FIG. 5A, block 510) 
Detect an occurrence of a first cardiac ,530 
event based on one of the heart 
sound signal or a cardiac electrical 
activity signal 
532 
Process the heart sound signal to 
detect an occurrence of a second 
cardiac event 
Determine the measure of interest as 
the time between the occurrence of 
the first cardiac event and the 
occurrence of the second cardiac 
event 
SI 536 
Select optimal stimulation therapy 
(return to FIG. 5A, block 512) 
FIG. 5C
Patent AU-2021270106-A1 (AU)
Title: Gold nanoparticle-containing medicine
Inventor: KATO HIROKI
IPC: A61K9/14
Filed: 2021-05-14
Abstract: The present invention pertains to a gold nanoparticle-containing medicine and a treatment for proliferative diseases using said medicine. The present invention also pertains to: a gold nanoparticle-containing medicine that is bound to an alpha ray-emitting isotope; and a treatment for proliferative diseases using said medicine.